IGM Biosciences Inc Financial Flexibility Index
IGM Biosciences Inc financial flexibility index. IGM Biosciences Inc (IGMS) has a Financial Flexibility Index of -8.38x as of June 2025. Free cash flow of $-50.79 Million (operating CF $-50.79 Million minus capex $1.00K) represents -8% of total liabilities ($6.06 Million). See IGM Biosciences Inc free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of IGM Biosciences Inc (2017–2024)
Financial flexibility index of IGM Biosciences Inc from 2017 to 2024. Historical Financial Flexibility Index trend for IGM Biosciences Inc across 8 annual periods. Check earnings quality score of IGM Biosciences Inc to evaluate the quality of earnings relative to operating cash generation.
IGM Biosciences Inc Financial Flexibility Index by Year (2017–2024)
IGM Biosciences Inc financial flexibility index by year from 2017 to 2024. Year-by-year free cash flow to debt coverage for IGM Biosciences Inc. For the full cash flow conversion analysis, see IGMS operating cash flow.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.68x | $-147.14 Million | $-153.00 Million | $217.54 Million | ▲ +17.2% |
| 2023 | -0.82x | $-179.85 Million | $-192.23 Million | $220.18 Million | ▼ -4345.3% |
| 2022 | 0.02x | $4.35 Million | $-5.85 Million | $226.24 Million | ▲ +100.9% |
| 2021 | -2.09x | $-111.09 Million | $-124.34 Million | $53.22 Million | ▼ -12.4% |
| 2020 | -1.86x | $-49.80 Million | $-67.30 Million | $26.82 Million | ▲ +8.3% |
| 2019 | -2.03x | $-42.78 Million | $-45.12 Million | $21.12 Million | ▼ -634.3% |
| 2018 | -0.28x | $-19.26 Million | $-20.04 Million | $69.81 Million | ▼ -15.9% |
| 2017 | -0.24x | $-9.97 Million | $-10.36 Million | $41.89 Million | — |